GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE")

Registered charity 1189729 · accounts filings on the Charity Commission register · also known as GRACE

GRACE exists to improve the lives of women diagnosed with gynaecological cancers. It aims to improve the detection and treatment of these cancers through raising awareness, funding research, pioneering medical equipment and provision of emotional support to women. The charity supports the delivery of clinical excellence and high-quality care within the South East.

Objects

THE RELIEF OF SICKNESS OF PATIENTS WITH GYNAECOLOGICAL CANCER THROUGH RESEARCH, HEALTH EDUCATION AND TRAINING, AND PROVISION OF EQUIPMENT, FACILITIES AND SUPPORT RESOURCES.

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£92k
Latest spending
£78k
Registered
2020
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity achieved its first surplus since the pandemic, with a net movement in funds of £14,943 for the year ended 31 March 2025. Per the trustees' report, unrestricted net assets of £89,468 provide sufficient funds to cover running costs for at least fifteen months, although this falls short of the stated eighteen-month reserves target. The financial position is described as stable and improved compared to the previous year's deficit.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: Fundraising (77% of income)
“Income from charitable activities: Fund raising 3 70,799”
Per its FY2025 accounts as filed with the Charity Commission.
Reserves position: below the charity's own stated reserves policy (held: £89k; policy: eighteen months)
“This falls short of Grace’s revised reserves target of eighteen months.”
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

Public profiles (found on the charity’s own website): facebook · instagram

Register events

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/03/2025£92k£78k
31/03/2024£79k£83k
31/03/2023£110k£98k
31/03/2022£73k£138k
31/03/2021£47k£107k

Common questions

Is GYNAE-ONCOLOGY RESEARCH AND CLINICAL EXCELLENCE ("GRACE") financially healthy?

Per its FY2025 accounts: The accounts state that the charity achieved its first surplus since the pandemic, with a net movement in funds of £14,943 for the year ended 31 March 2025. Per the trustees' report, unrestricted net assets of £89,468 provide sufficient funds to cover running costs for at least fifteen months, although this falls short of the stated eighteen-month reserves target. The financial position is described as stable and improved compared to the previous year's deficit. Its FY2025 accounts were independently examined.